How to improve initial diagnostic accuracy of kidney tumours in childhood?—A non-invasive approach
Int. J. Cancer. 2024
Transfusional hemosiderosis in childhood cancer patients and survivors
Pediatr Blood Cancer. 2024
Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia
© 2024 by American Society of Clinical Oncology
Fertility preservation in pediatric central nervous system tumors: A report from the Children’s Oncology Group
Pediatr Blood Cancer. 2024
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
Frontiers in Pediatrics
Minimally invasive and robotic-assisted approaches applied to pediatric surgical oncology
Pediatr Blood Cancer. 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Transplantation and Cellular Therapy (2024)
Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia
Haematologica | 109 June 2024
Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation
Transplantation and Cellular Therapy (2024)
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Transplantation and Cellular Therapy 29 (2023)
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children’s Oncology Group
Pediatr Blood Cancer. 2024;e31009.
Bilateral Wilms tumor with anaplasia: A report from the Children’s Oncology Group Study AREN0534
Pediatr Blood Cancer. 2024;e30981.
Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
© 2024 British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia
© 2024 by The American Society of Hematology
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Bone Marrow Transplantation (2021)
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Blood Cancer Journal
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging
Br J Ophthalmol 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials
Lancet Haematol 2021
Children’s Oncology Group’s 2023 blueprint for research: Central nervous system tumors
Pediatr Blood Cancer. 2021
Communication, academic and social outcomes of childhood cancer survivors with hearing loss: A systematic review
Pediatr Blood Cancer. 2021
Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline
Pediatr Blood Cancer. 2021
Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPROncology Committee/ASPNR White Paper
Pediatr Blood Cancer. 2021
Answers to common questions about COVID-19 vaccines in children with cancer
Pediatr Blood Cancer. 2021
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001
Pediatr Blood Cancer. 2021
Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit
Pediatr Blood Cancer. 2021
Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in a child with neuroblastoma relapse after autologous peripheral blood stem cell transplantation
Pediatr Blood Cancer. 2021
Prognostic value of detection of CD99+, CD45− cells in peripheral blood by flow cytometry in children with Ewing sarcoma
Pediatr Blood Cancer. 2021
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome
Pediatr Blood Cancer. 2021
Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review
Pediatr Blood Cancer. 2021
A new standard of care for childhood T-cell acute lymphoblastic leukemia?
Pediatr Blood Cancer. 2021
An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies
Pediatr Blood Cancer. 2021
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031
Pediatr Blood Cancer. 2021
Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remission
Pediatr Blood Cancer. 2021
Understanding decisions to participate in genomic medicine in children’s cancer care: A comparison of what influences parents, health care providers, and the general community
Pediatr Blood Cancer. 2021
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies
Pediatr Blood Cancer. 2021
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma
Pediatr Blood Cancer. 2021
Complementary and alternative medicine in children with diffuse intrinsic pontine glioma—A SIOPE DIPG Network and Registry study
Pediatr Blood Cancer. 2021
Trends in conditional survival and predictors of late death in neuroblastoma
Pediatr Blood Cancer. 2020
Use of quality indicators in neuroblastoma treatment: A feasibility assessment
Pediatr Blood Cancer. 2020
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up
Pediatr Blood Cancer. 2022
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial
Lancet Oncol 2020
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
The New England Journal of Medicine
Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
© 2020 by American Society of Clinical Oncology
Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia with Venetoclax and Azacitidine
© 2021 by American Society of Clinical Oncology
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
© 2020 American Society of Clinical Oncology.
Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes
European Journal of Medical Genetics
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
© 2022 by The American Society of Hematology
Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
Hemasphere 2020
Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing
Genes 2021
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report
Cancer
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second-generation tyrosine kinase inhibitor to an alternative TKI
Leukemia Research 111 (2021)
Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Cancers 2020
Gene Expression Analysis of Pediatric Acute Myeloid Leukemia Identified a Hyperactive ASXL1/BAP1 Axis Linked with Poor Prognosis and over Expressed Epigenetic Modifiers
Pediatric Hematology and Oncology
How I treat measurable (minimal) residual disease in acute leukemia after allogeneic hematopoietic cell transplantation
© 2020 by The American Society of Hematology
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib
American Journal of Hematology
Aberrant Expression of T-Cell-Associated Markers CD4 and CD7 on B-Cell Chronic Lymphocytic Leukemia
American Journal of Hematology
Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease
© 2020 by The American Society of Hematology
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial
© 2021 by The American Society of Hematology
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
Clinical Infectious Diseases
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
Society for Neuro-Oncology
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients
Int J Lab Hematol.
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis
Lancet Haematol 2020
Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia
Pediatr Blood Cancer.
Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype
© 2018 by The American Society of Hematology
Incidence trends of childhood acute lymphoblastic leukemia in Saudi Arabia: Increasing incidence or competing risks?
Cancer Epidemiology
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults
Best Practice & Research Clinical Haematology
